| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 99 | 60 | 68 | 31 | 85 | 71 | 86 | 62 | 87 | 68 | 98 | 80 | 130 | 66 | 115 | 123 | 140 | 78 | 142 | 129 | 186 | 113 | 157 | 119 | 174 | 130 | 104 | 175 | 279 | 187 | 204 | 121 | 130 | 145 | 112 | 52 | 156 | 70 | 101 | 96 | 120 | 92 | 75 | 126 | 161 | 84 |
| Expenses | 91 | 47 | 62 | 39 | 69 | 59 | 64 | 53 | 76 | 60 | 81 | 61 | 97 | 56 | 89 | 98 | 111 | 71 | 125 | 104 | 138 | 84 | 126 | 100 | 134 | 104 | 82 | 131 | 207 | 159 | 167 | 105 | 122 | 140 | 114 | 69 | 141 | 116 | 118 | 100 | 114 | 102 | 80 | 123 | 150 | 84 |
| EBITDA | 8 | 12 | 6 | -8 | 16 | 12 | 22 | 10 | 11 | 9 | 16 | 19 | 33 | 9 | 25 | 24 | 29 | 7 | 17 | 25 | 48 | 30 | 31 | 19 | 40 | 26 | 22 | 45 | 72 | 28 | 37 | 16 | 8 | 5 | -2 | -17 | 15 | -45 | -18 | -4 | 6 | -11 | -6 | 3 | 12 | 0 |
| Operating Profit % | 2 % | 20 % | 7 % | -26 % | 12 % | 16 % | 25 % | 14 % | 12 % | 9 % | 15 % | 18 % | 24 % | 13 % | 21 % | 18 % | 17 % | 8 % | 11 % | 17 % | 24 % | 25 % | 19 % | 13 % | 22 % | 19 % | 21 % | 25 % | 24 % | 14 % | 17 % | 10 % | 4 % | 2 % | -3 % | -36 % | 8 % | -67 % | -20 % | -6 % | 5 % | -12 % | -9 % | 2 % | 6 % | -1 % |
| Depreciation | 1 | 3 | 3 | 2 | 3 | 3 | 4 | 2 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 8 | 9 | 11 | 9 | 8 | 9 | 8 | 9 | 9 | 9 | 9 | 9 | 12 | 11 | 12 | 12 | 10 | 11 | 12 | 11 |
| Interest | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 4 | 3 | 4 | 4 | 3 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 4 | 5 | 6 | 6 | 7 | 6 | 6 | 7 | 7 | 9 | 10 | 10 | 11 | 8 | 7 | 8 | 8 |
| Profit Before Tax | 4 | 7 | 2 | -11 | 15 | 5 | 15 | 5 | 4 | 6 | 10 | 13 | 27 | 3 | 18 | 15 | 20 | -2 | 8 | 16 | 40 | 22 | 24 | 11 | 32 | 17 | 12 | 33 | 58 | 15 | 25 | 1 | -6 | -11 | -18 | -32 | -1 | -62 | -39 | -25 | -16 | -33 | -24 | -16 | -8 | -19 |
| Tax | 1 | 2 | -0 | -3 | 9 | 1 | 4 | 4 | 1 | 2 | 3 | 6 | 10 | 1 | 6 | 5 | 8 | -1 | 3 | 3 | 9 | 6 | 6 | 4 | 8 | 5 | 3 | 9 | 15 | 4 | 6 | 0 | -1 | -3 | -4 | -8 | 0 | -22 | 0 | 15 | 0 | 0 | 0 | 0 | -0 | 0 |
| Net Profit | 3 | 5 | 2 | -8 | 6 | 4 | 11 | 1 | 4 | 4 | 7 | 7 | 17 | 2 | 12 | 10 | 13 | -1 | 5 | 12 | 31 | 16 | 18 | 7 | 24 | 13 | 9 | 25 | 43 | 11 | 18 | 1 | -5 | -8 | -13 | -24 | -1 | -40 | -39 | -40 | -16 | -33 | -24 | -16 | -8 | -19 |
| EPS in ₹ | 1.74 | 2.66 | 1.05 | -4.03 | 2.88 | 1.93 | 5.74 | 0.36 | 1.77 | 2.04 | 3.44 | 3.67 | 8.78 | 0.08 | 5.92 | 5.10 | 6.50 | -0.57 | 2.70 | 6.22 | 15.94 | 8.27 | 9.12 | 3.61 | 12.24 | 6.63 | 4.63 | 12.63 | 21.97 | 5.82 | 9.34 | 0.43 | -2.54 | -4.18 | -6.85 | -12.41 | -0.50 | -20.26 | -19.66 | -20.59 | -8.20 | -16.85 | -11.35 | -7.04 | -3.48 | -8.40 |
Astec Lifesciences
Astec Lifesciences
748.20
+43.50
(6.17%)
Market Cap
1,667.20 Cr
PE Ratio
-23.60
Volume
4,14,236.00
Day High - Low
773.70 - 714.90
52W High-Low
941.75 - 513.40
Key Fundamentals
Market Cap
1,667.20 Cr
EPS
-37.79
PE Ratio
-23.60
PB Ratio
4.02
Book Value
175.29
EBITDA
0.50
Dividend Yield
0.00 %
Industry
Chemicals Sector
Pesticides & Agrochemicals Return on Equity
-20.69
Debt to Equity
1.60
Analyst Rating and Forecast
- By Refinitiv from1 analysts
Actual
Company News
View All News
Astec LifeSciences Limited held its 32nd AGM on July 31, 2026. Shareholders approved FY25-26 financials, re-elected Ashok V. Hiremath, and ratified cost auditor fees.
Astec Lifesciences Q1 Results: Net Loss Narrows YoYJul 31, 2026
Astec Lifesciences posts Q1 consolidated net loss of 187M rupees, narrowing from 330M loss YoY, as revenue declined to 836M rupees from 911M rupees.
Astec LifeSciences schedules its 32nd AGM on July 31, 2026 via VC/OAVM. FY26 consolidated total income rose to ₹45,322 Lakh; CDMO contributed 52% of total sales.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
495.00 | #1 41,786.38 | 18.45 | #1 52,502.00 | 11.41 | #1 2,220 | 58.52 | 26.26 | |
2,210.00 | 33,529.70 | 29.30 | 7,024.40 | -15.59 | 1,321 | -38.95 | 34.87 | |
421.95 | 21,061.45 | 36.05 | 3,385.00 | 3.56 | 543 | 20.44 | 27.89 | |
3,491.50 | 15,691.53 | 21.70 | 5,770.00 | 3.16 | 689 | 15.39 | 17.08 | |
742.05 | 6,694.81 | #1 10.67 | 5,409.80 | 23.53 | 681 | -38.38 | 45.68 | |
891.80 | 3,975.49 | 13.62 | 2,071.30 | 15.49 | 297 | 27.97 | 27.38 | |
200.03 | 3,889.96 | 31.33 | 2,631.40 | 6.54 | 164 | -274.07 | 38.92 | |
132.60 | 3,106.07 | 257.64 | 1,587.30 | #1 27.74 | 5 | 60.00 | 29.28 | |
235.82 | 3,057.86 | 113.42 | 538.30 | 19.68 | 18 | #1 232.50 | 35.50 | |
482.80 | 2,245.93 | 22.47 | 1,530.90 | 17.66 | 95 | 16.81 | 41.34 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
17.14 %
Net Income Growth
-39.94 %
Cash Flow Change
-860.83 %
ROE
-63.90 %
ROCE
-48.02 %
EBITDA Margin (Avg.)
-100.77 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 362 | 330 | 334 | 413 | 461 | 572 | 678 | 897 | 979 | 975 | 881 | 942 |
| Fixed Assets | 133 | 95 | 103 | 115 | 167 | 194 | 213 | 340 | 319 | 386 | 499 | 459 |
| Current Assets | 204 | 191 | 198 | 232 | 249 | 332 | 330 | 516 | 499 | 399 | 341 | 443 |
| Capital Work in Progress | 12 | 20 | 8 | 42 | 19 | 24 | 116 | 23 | 127 | 165 | 21 | 20 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 217 | 215 | 223 | 256 | 275 | 354 | 349 | 534 | 534 | 424 | 361 | 464 |
| Total Equity & Liabilities | 362 | 330 | 334 | 413 | 461 | 572 | 678 | 897 | 979 | 975 | 881 | 942 |
| Current Liabilities | 178 | 203 | 194 | 238 | 249 | 318 | 322 | 491 | 526 | 397 | 366 | 500 |
| Non Current Liabilities | 49 | 9 | 2 | 5 | 10 | 7 | 46 | 10 | 34 | 208 | 281 | 51 |
| Total Equity | 135 | 118 | 138 | 170 | 203 | 247 | 309 | 397 | 420 | 370 | 235 | 391 |
| Reserve & Surplus | 116 | 99 | 119 | 150 | 183 | 227 | 290 | 377 | 400 | 350 | 215 | 368 |
| Share Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 22 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | -0 | 2 | 1 | -3 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | 10 |
| Investing Activities | -19 | -17 | -18 | -49 | -53 | -74 | -73 | -104 | -113 | -135 | -15 | -4 |
| Operating Activities | 8 | -13 | 19 | 65 | 15 | 168 | -8 | 24 | 75 | 10 | -8 | -81 |
| Financing Activities | 12 | 31 | -1 | -18 | 37 | -95 | 81 | 81 | 38 | 125 | 24 | 95 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Jul 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 65.23 % | 65.20 % | 65.20 % | 65.19 % | 65.29 % | 65.29 % | 66.77 % | 66.77 % | 66.77 % | 66.76 % | 66.75 % | 66.75 % | 66.75 % | 66.75 % | 66.75 % | 66.75 % | 70.87 % | 70.87 % | 72.42 % | 72.42 % | 71.97 % | 71.97 % | 71.96 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.28 % | 1.25 % | 1.03 % | 0.53 % | 1.20 % | 0.25 % | 0.02 % | 0.02 % | 0.00 % | 0.04 % | 0.02 % | 0.01 % |
| DIIs | 9.76 % | 9.58 % | 11.36 % | 11.69 % | 11.16 % | 10.24 % | 9.83 % | 9.56 % | 9.58 % | 10.15 % | 9.15 % | 9.74 % | 7.88 % | 3.38 % | 4.51 % | 5.41 % | 4.34 % | 4.26 % | 4.01 % | 4.01 % | 3.17 % | 3.34 % | 3.33 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 19.06 % | 19.33 % | 18.06 % | 17.41 % | 17.46 % | 18.26 % | 18.02 % | 17.86 % | 16.81 % | 17.75 % | 17.91 % | 18.19 % | 19.62 % | 22.52 % | 21.95 % | 20.71 % | 19.62 % | 19.98 % | 18.96 % | 19.32 % | 20.87 % | 20.81 % | 20.48 % |
| Others | 5.94 % | 5.89 % | 5.38 % | 5.71 % | 6.09 % | 6.21 % | 5.38 % | 5.82 % | 6.85 % | 5.34 % | 6.19 % | 4.03 % | 4.49 % | 6.33 % | 6.26 % | 5.93 % | 4.91 % | 4.87 % | 4.59 % | 4.25 % | 3.95 % | 3.86 % | 4.22 % |
| No of Share Holders | 0 | 19,872 | 22,817 | 21,073 | 19,002 | 16,951 | 17,433 | 17,632 | 17,809 | 18,703 | 18,722 | 19,244 | 19,848 | 19,955 | 19,727 | 19,057 | 18,689 | 18,549 | 18,889 | 18,276 | 22,293 | 21,041 | 19,889 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.26 | 0.28 | 0.39 | 0.15 | 0.09 | 0.11 | 0.14 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 24 Jul 2021 |  Dividend | ₹ 1.50 /share | 22 Jul 2021 | 1,153.34 | 1,373.99 |
| 21 Jul 2022 | Dividend | ₹ 1.50 /share | 19 Jul 2022 | 1,815.32 | 2,053.13 |
| 22 Jul 2023 | Dividend | ₹ 1.50 /share | 21 Jul 2023 | 1,320.32 | 1,281.21 |
| 27 Jul 2023 |  Annual General Meeting | NA | 27 Jul 2023 | 1,320.32 | 1,238.53 |
| 29 Jul 2024 | Annual General Meeting | NA | 29 Jul 2024 | 1,274.65 | 1,273.21 |
| 25 Oct 2024 |  Quarterly Result Announcement | NA | 25 Oct 2024 | 1,088.08 | 1,064.11 |
| 27 Jan 2025 | Quarterly Result Announcement | NA | 27 Jan 2025 | 1,008.69 | 955.39 |
| 23 Apr 2025 | Quarterly Result Announcement | NA | 23 Apr 2025 | 699.75 | 757.08 |
| 04 Jul 2025 |  Rights | 1:7 | 04 Jul 2025 | 929.44 | 940.36 |
| 28 Jul 2025 | Annual General Meeting | NA | 28 Jul 2025 | 757.08 | 900.15 |
| 28 Jul 2025 | Quarterly Result Announcement | NA | 28 Jul 2025 | 897.60 | 900.15 |
| 29 Oct 2025 | Quarterly Result Announcement | NA | 29 Oct 2025 | 748.10 | 683.85 |
| 30 Jan 2026 | Quarterly Result Announcement | NA | 30 Jan 2026 | 660.85 | 575.40 |
| 27 Apr 2026 | Quarterly Result Announcement | NA | 27 Apr 2026 | 749.40 | 722.50 |
| 31 Jul 2026 | Annual General Meeting | NA | 31 Jul 2026 | 722.50 | 627.85 |
| 31 Jul 2026 | Quarterly Result Announcement | NA | 31 Jul 2026 | 684.90 | 627.85 |
Announcements
Response To Volume Movement Letter
6 days ago
6 days agoClarification sought from Astec Lifesciences Ltd6 days ago
6 days agoClosure of Trading Window9 days ago
9 days agoResponse To BSE Query Dated 18.09.2026Sep 18, 2026
Sep 18, 2026Clarification sought from Astec Lifesciences LtdSep 18, 2026
Sep 18, 2026Response To BSE E-Mail Seeking Clarification On Price MovementSep 11, 2026
Sep 11, 2026Clarification sought from Astec Lifesciences LtdSep 10, 2026
Sep 10, 2026Reply To BSE Query Regarding Volume Movement Dated September 9 2026Sep 09, 2026
Sep 09, 2026Clarification sought from Astec Lifesciences LtdSep 09, 2026
Sep 09, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2026
Aug 01, 2026Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 31, 2026
Jul 31, 2026Shareholder Meeting / Postal Ballot-Outcome of AGMJul 31, 2026
Jul 31, 202632Nd Annual General MeetingJul 31, 2026
Jul 31, 202632Nd Annual General MeetingJul 31, 2026
Jul 31, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2026
Jul 31, 2026Financial Result For The Quarter Ended June 30 2026Jul 31, 2026
Jul 31, 2026Board Meeting Outcome for Outcome Of Board MeetingJul 31, 2026
Jul 31, 2026Board Meeting Intimation for Intimation Of Board MeetingJul 21, 2026
Jul 21, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2026
Jul 15, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 09, 2026
Jul 09, 2026Intimation Of Annual General Meeting And Annual Report Of Financial Year 2025-26Jul 08, 2026
Jul 08, 2026Closure Of Register Of Members And Share Transfer BookJul 08, 2026
Jul 08, 2026Reg. 34 (1) Annual Report.Jul 08, 2026
Jul 08, 2026 Intimation Of "Annual General Meeting" And Annual Report Of Financial Year 2025-26Jul 08, 2026
Jul 08, 2026 Intimation Of "Annual General Meeting" And Annual Report Of Financial Year 2025-26Jul 08, 2026
Jul 08, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJul 04, 2026
Jul 04, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJul 04, 2026
Jul 04, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateJul 04, 2026
Jul 04, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJul 04, 2026
Jul 04, 2026Postal BallotJul 04, 2026
Jul 04, 2026Closure of Trading WindowJun 27, 2026
Jun 27, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 25, 2026
Jun 25, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJun 05, 2026
Jun 05, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 03, 2026
Jun 03, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotJun 02, 2026
Jun 02, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 01, 2026
Jun 01, 2026Reply On Significant Increase In The Volume Of SecurityJun 01, 2026
Jun 01, 2026Clarification Sought from Astec Lifesciences LtdJun 01, 2026
Jun 01, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2026
May 21, 2026Notice To Shareholders For Transfer Of Equity Shares And Dividend To Investor Education And Protection Fund (IEPF)May 20, 2026
May 20, 2026Updates- Grant Of Stock OptionsApr 30, 2026
Apr 30, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 28, 2026
Apr 28, 202632Nd AGMApr 27, 2026
Apr 27, 2026Book Closure For 32Nd Annual General MeetingApr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 27, 2026
Apr 27, 2026Financial ResultApr 27, 2026
Apr 27, 2026Board Meeting Outcome for Outcome Of Board MeetingApr 27, 2026
Apr 27, 2026Clarification To BSE Regarding Price MovementApr 20, 2026
Apr 20, 2026Board Meeting Intimation for Approval Of Financial ResultsApr 17, 2026
Apr 17, 2026Clarification sought from Astec Lifesciences LtdApr 17, 2026
Apr 17, 2026Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 ICICI Prudential Commodities Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.17% | |
ICICI Prudential Mid Cap Direct Plan-Growth | 0.00% | 0 | 0.00% | -0.01% | |
 Motilal Oswal BSE 1000 Index Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 Nippon India Small Cap Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.04% |
Technical Indicators
RSI(14)
Neutral 58.40
ATR(14)
Volatile 46.97
STOCH(9,6)
Neutral 27.39
STOCH RSI(14)
Oversold 18.66
MACD(12,26)
Bearish -2.58
ADX(14)
Strong Trend 40.77
UO(9)
Bearish 46.23
ROC(12)
Uptrend And Accelerating 2.96
WillR(14)
Neutral -47.29
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
